Rocuronium Bromide Injection
Product Images NDC 71872-7262

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Rocuronium Bromide (NDC 71872-7262). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medical Purchasing Solutions, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

71872-7262-01.pdp (71872 7262 01)

This is a description of a medication called Rocuronium Bromide injection, which is stored under refrigeration and is used for intravenous use only. The package insert should be consulted to determine the usual dosage for this paralyzing agent. Caution is advised, as respiratory arrest may occur, and facilities for artificial respiration should be immediately available. The medication is sold in a single vial, and opened vials should be used within 30 days. This product is distributed by Baxter Healthcare Corporation in Illinois and manufactured in Germany. It is repackaged and distributed by Medical Purchasing Solutions in Scottsdale, AZ.*

FDA Label Image

Rocuronium Structural Formula (Image 01)

FDA Label Image

Figure 1 (Rocuronium Function of Dose)

FDA Label Image

Figure 2 (Rocuronium Function of Dose)

FDA Label Image

Figure 3 (Rocuronium Clinical Durations)

FDA Label Image

Rocuronium Representative Container Label 50 mg 43066-007-10 (Image 05)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.